The Multicenter Prospective Randomized Controlled Trial Evaluating Efficacy of Ganglionic plexi (GP) Ablation in the Surgery for Atrial Fibrillation: Japan GP Ablation trial

The Multicenter Prospective Randomized Controlled Trial Evaluating Efficacy of Ganglionic plexi (GP) Ablation in the Surgery for Atrial Fibrillation: Japan GP Ablation trial - J-GPA trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1032180079

Enrollment

300

Registered

2019-01-11

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing cardiac surgery

Interventions

Maneuver (Standardization of atrial fibrillation procedure, Standerdization of GP mapping and ablation technique)s

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have indication of atrial fibrillation surgery in the guidelines for non-pharmacotherapy of Cardiac Arrhythmias

Exclusion criteria

Exclusion criteria: 1) Low cardiac function (EF<40%) 2) History of RFCA 3) Use of catechoramine 4) Thrombus in left atrial appendage 5) Pacemaker implantation 6) Non consent

Design outcomes

Primary

Measure	Time frame
Recurrence of atrial tachycardia and atrial fibrillation in 2 years.	—

Secondary

Measure	Time frame
Recurrence of atrial tachycardia and atrial fibrillation, motality, and major adverse cardiac events in 6 months or 1 year.	—

Contacts

Public ContactNaomi Ozawa

School of Medicine, Teikyo University

naozawa@med.teikyo-u.ac.jp+81-3-3964-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026